SynthesisThe Cochrane database of systematic reviews2026

Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.

Francesco Nonino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.